PharmaShots | Incisive News in 3 Shots

Subscribe Now

AZD1222

AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

September 1, 2020

AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19

AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19

September 1, 2020

AstraZeneca Signs an Agreement with Emergent BioSolutions to Expand Manufacturing of AZD1222 for COVID-19

AstraZeneca Signs an Agreement with Emergent BioSolutions to Expand Manufacturing of AZD1222 for COVID-19

July 28, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us